SGRQ = St. George Respiratory Questionnaire; SF-36 = Medical Outcomes Study 36-item short form; DLCO = diffusing capacity of the lung for carbon monoxide; NS = not significant; IVC = inspiratory ...

Setrusumab receives Breakthrough Therapy designation from the FDACash of $80.5 million as of September 30, 2024, expected to fund operations into ...

A recent study showed that the COPD assessment test was reliable and responsive for assessing health status in fibrotic ...

George's Respiratory Questionnaire (SGRQ) score with dupilumab versus placebo was -3.4 points (95% CI -5.0 to -1.8, nominal ...

SGRQ total score averaged over 24 wk: cilomilast improved ~3.6 points vs placebo worsened ~0.5 points (p < 0.001) pts. exacerbation-free at 24 wk: cilomilast 74% vs placebo 62% (p = 0.008 ...

George’s Respiratory Questionnaire (SGRQ). Data from both studies were published in separate manuscripts in The New England Journal of Medicine (BOREAS and NOTUS). Safety results in both studies ...

Setrusumab receives Breakthrough Therapy designation from the FDA Cash of $80.5 million as of September 30, 2024, expected to fund operations into 2027 LONDON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mereo ...

In both trials, health-related quality of life was assessed using the St. George’s Respiratory Questionnaire (SGRQ) responder analysis which was defined as an improvement in SGRQ score from ...